BUSINESS WIRE)--Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused ... M.D., Medical Director of Pinnacle Clinical Research in San Antonio, TX, visiting professor of Hepatology at the University of Oxford, UK.
News
- Axcella's Late-Breaker Data from AXA1125-003 Clinical Study Presented at the EASL Digital ...
- Metacrine Presents Positive MET409 Phase 1b Clinical Data in NASH Patients at the Digital ...
27, 2020 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on discovering and developing ... clinical professor of medicine at the University of Texas Health San Antonio and a principal ...
- Texas given emergency exemption to use long-lasting antiviral product on American Airlines
Allied BioScience CEO Mike Ruley joined David Johnson on @KRLD's CEO Spotlight to discuss the @EPA's approval for the use of #SurfaceWise2 to ...
- Washington University spit test approved by FDA for virus
The St. Louis-area university worked with biotechnology company Fluidigm to develop the test, which allows people to collect their own testing ...
- Madrigal Pharma (MDGL) to Present Secondary Analyses of Data from Phase 2 NASH Study of ...
... Commonwealth University, Inova Campus and Affiliate Professor of Biomedical Sciences at George Mason University. ... University of Oxford, Oxford, England and Medical Director Pinnacle Clinical Research San Antonio, TX.